Siyi Xu Selected Research

Siyi Xu Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 11/2013
5	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2023 - 07/2015
4	Melanoma (Melanoma, Malignant) 12/2023 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 07/2018
4	Chronic Hepatitis B 01/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2018
3	Stroke (Strokes) 01/2024 - 01/2020
3	Infections 12/2023 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 02/2024 - 11/2017
2	Ischemic Stroke 01/2024 - 01/2020
2	Breast Neoplasms (Breast Cancer) 10/2023 - 10/2023
2	Brain Edema (Cerebral Edema) 08/2023 - 11/2018
2	Glioma (Gliomas) 04/2022 - 01/2022
2	Genomic Instability 04/2022 - 01/2021
2	Memory Disorders (Memory Loss) 01/2021 - 08/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Epilepsy (Aura) 01/2024
1	Lentivirus Infections 12/2023
1	Cognitive Dysfunction 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Hepatitis B 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2022
1	Infertility (Sterility) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 08/2020
1	Inflammation (Inflammations) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Adenocarcinoma of Lung 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Papillary Thyroid Cancer 01/2018
1	Carcinogenesis 01/2018
1	Carcinoma (Carcinomatosis) 11/2017

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2018
7	Long Noncoding RNAIBA 01/2019 - 11/2017
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2017
5	InterferonsIBA 12/2023 - 01/2021
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Hepatitis B e AntigensIBA 01/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 04/2022 - 11/2021
3	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 11/2018 - 07/2015
2	LipidsIBA 01/2024 - 12/2023
2	InflammasomesIBA 12/2023 - 01/2023
2	6-methyladenineIBA 01/2023 - 11/2021
2	Interferon-alpha (Interferon Alfa)IBA 12/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 08/2020
2	Peptides (Polypeptides)IBA 08/2020 - 04/2016
2	Glutamic Acid (Glutamate)FDA Link 11/2018 - 04/2016
1	NitrosaminesIBA 02/2024
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2024
1	Apolipoproteins E (ApoE)IBA 01/2024
1	Carrier Proteins (Binding Protein)IBA 01/2024
1	CholesterolIBA 01/2024
1	gamma-Aminobutyric Acid (GABA)IBA 01/2024
1	growth arrest-specific protein 6IBA 01/2024
1	Pentylenetetrazole (Metrazol)IBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	CD40 Ligand (CD40L)IBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	PerforinIBA 12/2023
1	PuromycinIBA 12/2023
1	Granzymes (Granzyme)IBA 12/2023
1	Estrogen ReceptorsIBA 10/2023
1	Histone Deacetylase InhibitorsIBA 08/2023
1	SilverIBA 08/2023
1	Vorinostat FDA Link 08/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	CationsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Flap EndonucleasesIBA 04/2022
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 04/2022
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	Histone Deacetylase 1IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	N-methyladenosineIBA 11/2021
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2021
1	Therapeutic UsesIBA 08/2020
1	xingnaojingIBA 08/2020
1	Excitatory Amino AcidsIBA 08/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	Neuroprotective AgentsIBA 11/2018
1	N-acetylaspartate (N-acetyl aspartate)IBA 11/2018
1	Competitive Endogenous RNAIBA 01/2018
1	Messenger RNA (mRNA)IBA 11/2017

Therapy/Procedure

9	Therapeutics 10/2023 - 11/2017
2	Immunotherapy 01/2023 - 01/2022
1	Precision Medicine 02/2024
1	Nephrectomy 01/2024
1	Ligation 04/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2020
1	Treatment Delay 01/2020